Skip to content

Clinical trials

Phase 3 Prostatic Hyperplasia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Phase 3 Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20042
20056
20066
20074
20083
20097
20106
20115
20121
20136
20144
20152
20164
20181
20193
20202
20214
20241
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Terminated9
Not yet recruiting7
Unknown status6
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
Sanofi6
GlaxoSmithKline5
Health Ever Bio-Tech Co., Ltd.4
Nymox Corporation4
AEterna Zentaris3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
University of Manitoba3
Watson Pharmaceuticals3
Astellas Pharma Europe B.V.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia80
Lower Urinary Tract Symptoms12
Erectile Dysfunction5
Hyperplasia3
Prostatic Neoplasms2
Urinary Bladder Neck Obstruction2
Urinary Bladder, Overactive2
Urinary Retention2
Genital Diseases, Male1
Metabolic Syndrome1

Trials

Showing 26 to 50 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.